in World News European psychiatrists warn against ‘experimental’ and harmful transgender medicine
by
The European Society of Child and Adolescent Psychiatry (ESCAP) urged healthcare providers ‘not to promote experimental and unnecessarily invasive treatments with unproven psycho-social effects.’
(LifeSiteNews) — A major European psychiatric organization has warned doctors against promoting “experimental” transgender “treatments” to gender-confused children and adolescents
The European Society of Child and Adolescent Psychiatry (ESCAP) published a policy statement urging healthcare providers “not to promote experimental and unnecessarily invasive treatments with unproven psycho-social effects and, therefore, to adhere to the ‘primum-nil-nocere’ (first, do no harm) principle.”
The scientists of ESCAP highlighted the “poor reliability and instability of a gender dysphoria diagnosis in a specific child over time” and the “possible effects of the decisions to block puberty or preventing medical transitioning on a child’s psychosocial development.”
The report also stressed that “research findings are published solely on the grounds of quality criteria and not based on their findings.” In a post on X, formerly known as Twitter, the Society for Evidence-Based Gender Medicine (SEGM) interpreted this statement to mean that many recent studies reporting favorably about so-called “gender transition” are “deeply methodologically flawed.”
While the ESCAP report remained open to the possibility that some children might benefit from so-called “gender-affirming care,” it underscored the lack of quality research to accurately determine the risk-benefit ratio of interventions such as hormone blockers and mutilating surgeries.